Climb Biotherapeutics, Inc. CLYM
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Climb Biotherapeutics, Inc. is a company in the biotechnology industry, focusing on the development and commercialization of novel therapeutic solutions. Primarily, it plays a role in advancing treatments for conditions that lack efficient medical solutions, positioning itself at the forefront of innovation in health c…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees28
TickerCLYM
Statistics
Market Cap$541.9M
Revenue (TTM)$0
Net Income-$59.9M
Net Margin—
EPS$-0.88
P/E-13.00
P/S—
P/B3.69
EV/EBITDA-6.48
ROE-30.9%
Dividend Yield—
Price$11.35
Data: Twelve Data · Revenue = mcap / P/S